Cite Filings / ARCT
Feed Companies Filings Check
Sign in

CIK 0001768224

  • Accelerated filer
  • Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 858-900-2660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Filings Financials Insiders Search text
All 418 Financials 135 Shareholder Meetings 10 Executive Compensation 121 Insider Trading 149 Beneficial Ownership Interest 68 Business Combinations 107 Public Offerings 28 Mutual Funds and ETFs 9 Others 35
›
Filed in
  1. No filings match these filters. Clear filters
  2. 4 Derivatives Options or other derivatives 2019-10-29
  3. 3 Insider Initial Statement of Ownership 2019-09-24
  4. 4 Open-market buy Director bought 2,300 shares at $10.58 ($24,334) 2019-09-17
  5. 4 Open-market buy Kummerfeld Keith C bought 500 shares at $10.69 ($5,347) 2019-09-12
  6. 4 Open-market buy President and CEO bought 5,000 shares at $11.22 ($56,100) 2019-08-30
  7. 4 Open-market buy ● Chief Financial Officer bought 10,000 shares at $10.90 ($109,000) 2019-08-26
  8. 4 Open-market buy Director bought 9,113 shares at an average $10.94 ($99,672) 2019-08-21
  9. 3 Insider Initial Statement of Ownership 2019-06-26
  10. 3 Insider Initial Statement of Ownership 2019-06-25

Page 8 of 8 · 149 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…